Phase II study of gemcitabine, carboplatin and VELIPARIB (ABT-888) in refractory testicular germ cell cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2016
At a glance
- Drugs Carboplatin (Primary) ; Gemcitabine (Primary) ; Veliparib (Primary)
- Indications Germ cell and embryonal neoplasms; Seminoma
- Focus Therapeutic Use
- 26 Jul 2016 New trial record